InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,687.51
(
-0.32%
)
Post# of 251719
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 77793

Friday, 10/29/2010 4:45:50 PM

Friday, October 29, 2010 4:45:50 PM

Post# of 251719
Oversulfated chondroitin sulfate, the heparin contaminant MNTA helped the FDA characterize in 2008 (#msg-28748329), is still showing up in some heparin sold in the US. This is today’s alert from the FDA and the accompanying PR from B. Braun Medical (the company whose heparin was recalled):

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm231739.htm

http://www.fda.gov/Safety/Recalls/ucm231639.htm

The continued presence of OSCS in the US heparin supply can only be good for MNTA, IMO.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up